A Pill To Cure Lung Cancer
© euthman
A drug maker, Pfizer, who is very well known to treat millions with their medicines is set to roll out a twice a day type pill to cure lung cancer which would be given to few chosen candidates round the year.
The food and drug administration (FDA) approved Pfizer's Xalkori to treat patients who have small lung cancer due to genetic variation. The FDA approved the pill in combination with a genetic test to figure out who has the best chance to respond to the medicine. The new lung cancer pill would cost about $9,600 a month. But the company promises that the results would be substantial.
There some common side effects of the pill like vision problems, nausea, diarrhoea etc. these side effects would be rarely seen in less than 2 per cent of patients.